Alnylam Pharmaceuticals Inc (ALNY)
149.30
-1.92
(-1.27%)
USD |
NASDAQ |
May 17, 16:00
149.30
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Gross Profit (TTM): 1.682B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.682B |
December 31, 2023 | 1.518B |
September 30, 2023 | 1.448B |
June 30, 2023 | 1.005B |
March 31, 2023 | 955.39M |
December 31, 2022 | 868.60M |
September 30, 2022 | 805.70M |
June 30, 2022 | 737.48M |
March 31, 2022 | 735.27M |
December 31, 2021 | 704.14M |
September 30, 2021 | 623.81M |
June 30, 2021 | 572.90M |
March 31, 2021 | 475.13M |
December 31, 2020 | 414.80M |
September 30, 2020 | 333.77M |
June 30, 2020 | 294.56M |
March 31, 2020 | 250.92M |
December 31, 2019 | 194.69M |
September 30, 2019 | 154.55M |
June 30, 2019 | 91.64M |
March 31, 2019 | 81.15M |
December 31, 2018 | 73.11M |
September 30, 2018 | 91.66M |
June 30, 2018 | 106.83M |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
91.64M
Minimum
Jun 2019
1.682B
Maximum
Mar 2024
693.28M
Average
663.98M
Median
Gross Profit (TTM) Benchmarks
Pfizer Inc | 31.64B |
BridgeBio Pharma Inc | 216.20M |
Ionis Pharmaceuticals Inc | 766.68M |
Johnson & Johnson | 61.53B |
Blueprint Medicines Corp | 273.65M |